Edwards Lifesciences Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Edwards Lifesciences Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2010 to Q3 2024.
  • Edwards Lifesciences Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 598M shares, a 1.87% decline year-over-year.
  • Edwards Lifesciences Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 609M shares, a 2.37% decline from 2022.
  • Edwards Lifesciences Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 624M shares, a 1.11% decline from 2021.
  • Edwards Lifesciences Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 631M shares, a 0.11% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 598M -11.4M -1.87% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 604M -6M -0.98% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 604M -6.8M -1.11% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-29
Q4 2023 609M -14.8M -2.37% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-12
Q3 2023 610M -15M -2.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 610M -16.4M -2.62% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 611M -18.5M -2.94% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q4 2022 624M -7M -1.11% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-12
Q3 2022 625M -7.2M -1.14% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 627M -3.2M -0.51% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 629M -1.9M -0.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 631M -700K -0.11% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-12
Q3 2021 632M +700K +0.11% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 630M +9.6M +1.55% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 631M -3.8M -0.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 632M -4.8M -0.75% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-13
Q3 2020 631M -5.3M -0.83% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 620M -15.9M -2.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 635M +423M +199% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 637M -4.2M -0.66% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-14
Q3 2019 636M +423M +198% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-26
Q2 2019 636M +422M +197% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-27
Q1 2019 212M -2.9M -1.35% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-28
Q4 2018 641M +425M +197% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-12
Q3 2018 213M -3M -1.39% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-25
Q2 2018 214M -1.7M -0.79% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 215M -1.3M -0.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-26
Q4 2017 216M -1.9M -0.87% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-14
Q3 2017 216M -1.9M -0.87% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 216M -1.6M -0.74% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 216M -1.4M -0.64% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 218M -2.5M -1.14% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-15
Q3 2016 218M -1.8M -0.82% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-27
Q2 2016 217M -2.6M -1.18% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 218M -2.8M -1.27% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q4 2015 220M +3.3M +1.52% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 220M +112M +103% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 220M +113M +105% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 221M +112M +103% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q4 2014 217M -10.6M -4.66% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 108M -4.5M -3.99% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-29
Q2 2014 107M -7.3M -6.36% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-29
Q1 2014 109M -8M -6.87% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q4 2013 228M +109M +92.4% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 113M -6.1M -5.13% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
Q2 2013 115M -3.7M -3.13% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 117M -1.5M -1.27% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 118M -1.1M -0.92% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-20
Q3 2012 119M 0 0% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 118M -1.6M -1.33% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 118M -2.5M -2.08% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q4 2011 119M +200K +0.17% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-28
Q3 2011 119M +100K +0.08% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 120M +1.2M +1.01% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 121M +1.5M +1.26% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q4 2010 119M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 119M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 119M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 119M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.